P

Inventor

BEAUGLEHOLE ANTHONY

US9 patents
⚠️ This page may combine multiple inventors who share the name “BEAUGLEHOLE ANTHONY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LEWIS AND CLARK PHARMACEUTICALS INC

3 patents
US9067963B2Jun 30, 2015

N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as A2A agonists

LEWIS AND CLARK PHARMACEUTICALS INC30 citations91
US9822141B2Nov 21, 2017

N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as A2A agonists

LEWIS AND CLARK PHARMACEUTICALS INC1 citations49
US9593118B2Mar 14, 2017

Xanthine-substituted alkynyl carbamates/reverse carbamates as A2B antagonists

LEWIS AND CLARK PHARMACEUTICALS INC0 citations39

THOMPSON ROBERT D

2 patents
US7875608B2Jan 25, 2011

Substituted 8-[6-amino-3pyridyl]xanthines

THOMPSON ROBERT D9 citations81
US8293720B2Oct 23, 2012

Substituted 4-{3-[6-amino-9-(3, 4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists

THOMPSON ROBERT D2 citations60

ADENOSINE THERAPEUTICS LLC

1 patent
US7217702B2May 15, 2007

Selective antagonists of A2A adenosine receptors

ADENOSINE THERAPEUTICS LLC12 citations82

THOMPSON ROBERT DOUGLAS

1 patent
US8058259B2Nov 15, 2011

Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists

THOMPSON ROBERT DOUGLAS10 citations76

THOMPSON ROBERT

1 patent
US8252767B2Aug 28, 2012

Substituted 4-{3-[6-amino-9-(3, 4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists

THOMPSON ROBERT2 citations55

TROVIS PHARMACEUTICALS LLC

1 patent
US7985754B2Jul 26, 2011

Selective antagonists of A2A adenosine receptors

TROVIS PHARMACEUTICALS LLC1 citations45